NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	2.63	7.27	4.95	4.91	7.22
Short-Term Investments	2	-	-	-	-
Cash & Short-Term Investments	4.63	7.27	4.95	4.91	7.22
Cash Growth	-36.28%	46.66%	0.86%	-31.93%	-49.05%
Accounts Receivable	0.13	0.1	0.05	0.04	0.12
Receivables	0.13	0.1	0.05	0.04	0.12
Prepaid Expenses	0.04	0.03	0.04	0.05	0.06
Total Current Assets	4.8	7.4	5.04	5.01	7.4
Property, Plant & Equipment	0.09	0	0.01	0.01	0.02
Long-Term Investments	0.03	-	-	-	-
Other Intangible Assets	10.27	9.57	0.39	0.27	0.32
Total Assets	15.18	16.96	5.44	5.29	7.74

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	0.27	0.15	0.08	0.59	2.17
Accrued Expenses	0.02	-	0	0.01	0.05
Current Portion of Leases	0.05	-	-	-	-
Total Current Liabilities	0.34	0.15	0.09	0.6	2.22
Long-Term Leases	0.04	-	-	-	-
Total Liabilities	0.37	0.15	0.09	0.6	2.22

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	38.81	34.26	25.52	25.27	25.27
Retained Earnings	-26.71	-23.28	-22.04	-22.99	-22.6
Comprehensive Income & Other	2.71	5.84	1.87	2.41	2.84
Shareholders' Equity	14.81	16.81	5.35	4.69	5.52
Total Liabilities & Equity	15.18	16.96	5.44	5.29	7.74

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	0.09	-	-	-	-
Net Cash (Debt)	4.54	7.27	4.95	4.91	7.22
Net Cash Growth	-37.48%	46.66%	0.86%	-31.93%	-49.05%
Net Cash Per Share	0.01	0.05	0.03	0.03	0.05
Filing Date Shares Outstanding	342.06	332.58	144.6	143.47	143.47
Total Common Shares Outstanding	342.06	332.58	144.6	143.47	143.47
Working Capital	4.46	7.25	4.96	4.41	5.18
Book Value Per Share	0.04	0.05	0.04	0.03	0.04
Tangible Book Value	4.54	7.25	4.96	4.42	5.2
Tangible Book Value Per Share	0.01	0.02	0.03	0.03	0.04

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 25, 2026

Data Sources Report a data error